Pharmacological effects of BM-593, a novel sulfonylurea acting as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor on human platelets and isolated smooth muscles.

Stéphanie Rolin, Jacques Delarge, Bernard Masereel, Jean-Michel Dogné

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationAbstract book - XVèmes Journées franco-belges de pharmacochimie
Publication statusPublished - 2001

Cite this